SAM
Sandell Asset Management’s Pacira BioSciences PCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-140,000
| Closed | -$6.34M | – | 55 |
|
|
2019
Q4 | $6.34M | Hold |
140,000
| – | – | 1.03% | 18 |
|
|
2019
Q3 | $5.33M | Buy |
140,000
+10,100
| +8% | +$385K | 1.79% | 13 |
|
|
2019
Q2 | $5.65M | Hold |
129,900
| – | – | 0.64% | 22 |
|
|
2019
Q1 | $4.94M | Sell |
129,900
-21,700
| -14% | -$826K | 0.88% | 20 |
|
|
2018
Q4 | $6.52M | Sell |
151,600
-41,500
| -21% | -$1.79M | 0.72% | 13 |
|
|
2018
Q3 | $9.49M | Hold |
193,100
| – | – | 0.73% | 17 |
|
|
2018
Q2 | $6.19M | Hold |
193,100
| – | – | 0.36% | 22 |
|
|
2018
Q1 | $6.02M | Sell |
193,100
-183,000
| -49% | -$5.7M | 0.67% | 24 |
|
|
2017
Q4 | $17.2M | Hold |
376,100
| – | – | 2.28% | 13 |
|
|
2017
Q3 | $14.1M | Buy |
376,100
+328,500
| +690% | +$12.3M | 1.62% | 18 |
|
|
2017
Q2 | $2.27M | Buy |
+47,600
| New | +$2.27M | 0.56% | 19 |
|